Paolo Rovero

Prof. Paolo Rovero

Department of NeurFarBa, University of Florence
orcid

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 1993 in Journal of Autonomic Pharmacology
Verified
Journal Article
Closed access
PDF file
CMCarlo Alberto Maggi
Carlo Alberto Maggi
RPRiccardo Patacchini
Riccardo Patacchini
PRPaolo Rovero
Paolo Rovero
AGAntonio Giachetti
Antonio Giachetti

1 July 2014 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
FPFederico Pratesi
Federico Pratesi
IDIlaria Dioni
Ilaria Dioni
CTCristina Tommasi
Cristina Tommasi
MAMaria Claudia Alcaro
Maria Claudia Alcaro
IPIlaria Paolini
Ilaria Paolini
PMPaola Migliorini
Paola Migliorini
Background Histone deimination regulates gene function and contributes to antimicrobial response, allowing the formation of neutrophil extracellular traps (NETs). Deiminated proteins are target of anti-citrullinated peptides antibodies (ACPA) in rheumatoid arthritis (RA). Objective The objective of this paper is to test the hypothesis that RA sera react with deiminated histones contained in NETs. Methods Neutrophils from peripheral blood were stimulated with A23187 and acid treated; NETosis was induced by phorbol myristate acetate, and NET proteins were isolated. Sera were tested by immunoblot on acid extracted proteins from neutrophils and from NETs, and by ELISA on deiminated histone H4 or H4-derived peptides. Bands reactive with RA sera were excised from gels, digested with trypsin and subjected to matrix-assisted laser desorption/ionisation time of flight (MALDI-TOF) analysis, before and after derivatisation to detect citrullinated peptides. Results RA sera reacted with a deiminated antigen of 11 KDa from activated neutrophils, recognised also by anti-H4 and antideiminated H4 antibodies. A similar reactivity was observed with NET proteins. The antigen from neutrophils or NETs was identified as citrullinated H4 by MALDI-TOF analysis. By ELISA, RA sera bound in vitro citrullinated H4. Citrullinated H4 14–34 and 31–50 peptides detected antibodies in 67% and 63% of RA sera and in less than 5% of controls; antibody titre was correlated with anti-CCP2. Conclusions Citrullinated H4 from activated neutrophils and NETs is a target of antibodies in RA, and synthetic citrullinated H4-derived peptides are a new substrate for ACPA detection. As NETosis can generate antigens for ACPA, these data suggest a novel connection between innate and adaptive immunity in RA.

20 May 2008 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
SCSonia Cantel
Sonia Cantel
AIAlexandra Le Chevalier Isaad
Alexandra Le Chevalier Isaad
MSMario Scrima
Mario Scrima
JLJay J. Levy
Jay J. Levy
RDRichard D. DiMarchi
Richard D. DiMarchi
MCMichael Chorev
Michael Chorev

19 July 1990 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
CMCarlo Alberto Maggi
Carlo Alberto Maggi
RPRiccardo Patacchini
Riccardo Patacchini
SGSandro Giuliani
Sandro Giuliani
PRPaolo Rovero
Paolo Rovero
SDStephane Dion
Stephane Dion
AMAlberto Meli
Alberto Meli
1 We have compared the ability of various tachykinins and selective tachykinin receptor agonists to induce contraction of the endothelium-denuded rabbit pulmonary artery (RPA) and hamster trachea (HT) and have estimated the affinity of some newly developed NK2 selective antagonists in the same tissues. 2 In confirmation of previous findings, experiments with the agonists indicated that NK2 receptors are the main if not the sole mediators of the response to tachykinins in both RPA and HT. No evidence for significant degradation of neurokinin A (NKA) was found in either tissue when experiments were repeated in the presence of a mixture of peptidase inhibitors (thiorphan, captopril and bestatin, 1 μm each). 3 The peptide antagonists tested were: Peptide I = [Tyr5, d-Trp6,8,9, Arg10]-NKA(4–10); Peptide II = [Tyr5, d-Trp6,8,9, Arg10]-NKA(3–10); Peptide III = Ac-Leu-Asp-Gln-Trp-Phe-Gly-NH2. The three peptides produced a concentration-dependent rightward shift of the concentration-response curve to NKA in both RPA and HT with no significant depression of the maximal response attainable. The slopes of the Schild plots were not significantly different from unity, indicating a competitive antagonism. Peptides I and II were about 100 times more potent in the RPA than in the HT, while Peptide III was about 100 times more potent in the HT than RPA. 4 The pA2 values obtained in these two tissues with the three antagonists were not significantly different when tested in the absence or presence of peptidase inhibitors, or when a selective NK2 receptor agonist, [βAla8]-NKA(4–10) was used instead of NKA. Similar pA2 values were obtained after 15 or 90 min of incubation with the antagonists. Peptides I, II and III had no inhibitory effect on contractions produced by noradrenaline in the RPA or by carbachol in the HT. 5 Peptides I, II and III showed weak or no antagonistic activity toward the vasodilatator effect of substance P in the dog carotid artery (NK1 receptor-mediated) or toward the contractile effect of neurokinin B in the rat portal vein (NK3 receptor-mediated). 6 These results provide pharmacological evidence for heterogeneity of NK2 receptors in the RPA and HT. The NK2 receptors present in these tissues are not discriminated by natural tachykinins or selective agonists, but are recognized with very different affinity by NK2 receptor antagonists.

10 November 2005 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
ZKZbigniew Kaminski
Zbigniew Kaminski
BKBeata Kolesinska
Beata Kolesinska
JKJustyna Kolesińska
Justyna Kolesińska
GSGiuseppina Sabatino
Giuseppina Sabatino
MCMario Chelli
Mario Chelli
Anna Maria PapiniAnna Maria Papini
Anna Maria Papini

1 April 2012 in ASN Neuro
Verified
Journal Article
Open access
CTChiara Testa
Chiara Testa
FNFrancesca Nuti
Francesca Nuti
JHJoussef Hayek
Joussef Hayek
CFClaudio De Felice
Claudio De Felice
MCMario Chelli
Mario Chelli
Anna Maria PapiniAnna Maria Papini
Anna Maria Papini
ASDs (autism spectrum disorders) are a complex group of neurodevelopment disorders, still poorly understood, steadily rising in frequency and treatment refracto...